Advertisement
Screener

Alphabet Inc. Historic Quarter Change: USA Other Stocks, Sold Out

Alphabet Inc. historic quarter change: USA Other Stocks, Sold out

In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 10 quarters from 2023-12-31 to 2026-06-30, Alphabet Inc. opened 0 positions, added to 0, reduced 1 and sold out of 9.

  • Q1 2026: Stock QUINCE THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 189,122.
  • Q3 2025: Stock VERVE THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 12,168,489.
  • Q2 2025: Stock LYELL IMMUNOPHARMA INC; Country of operation United States; Class COM; Shares before 5,865,125.
  • Q2 2025: Stock KRONOS BIO INC; Country of operation United States; Class COM; Shares before 1,438,232.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1652044), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-07); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-08); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-13); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-07); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-01); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-02); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-07); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-11-08); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-02); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-03). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2022-09-30.

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2026QUINCE THERAPEUTICS INC
CUSIP 22053A107
United StatesCOM189,1220-189,122$633,559$0-$633,5592026-05-08
Q3 2025VERVE THERAPEUTICS INC
CUSIP 92539P101
United StatesCOM12,168,4890-12,168,489$136,652,131$0-$136,652,1312025-11-07
Q2 2025LYELL IMMUNOPHARMA INC
CUSIP 55083R104
United StatesCOM5,865,1250-5,865,125$3,167,168$0-$3,167,1682025-08-01
Q2 2025KRONOS BIO INC
CUSIP 50107A104
United StatesCOM1,438,2320-1,438,232$1,193,733$0-$1,193,7332025-08-01
Q1 2025INVITAE CORP
CUSIP 46185L103
United StatesCOM235,6060-235,606$0$0$02025-05-02
Q4 2024RAPT THERAPEUTICS INC
CUSIP 75382E109
United StatesCOM540,2700-540,270$1,085,943$0-$1,085,9432025-02-07
Q3 2024BENSON HILL INC
CUSIP 082490103
United StatesCOMMON STOCK15,352,2710-15,352,271$2,302,841$0-$2,302,8412024-11-08
Q2 2024DESKTOP METAL INC
CUSIP 25058X105
United StatesCOM CL A11,048,7300-11,048,730$9,722,882$0-$9,722,8822024-08-02
Q1 2024SCIENCE 37 HOLDINGS INC
CUSIP 808644207
COM NEW160,3640-160,364$856,343$0-$856,3432024-05-03

Similar Firms

Firm NameCountry13F ValueHoldings
Arbejdsmarkedets TillaegspensionDenmark$4.020B169
JOURNEY STRATEGIC WEALTH LLCUnited States$4.029B3,980
CARY STREET PARTNERS FINANCIAL LLCUnited States$4.037B1,357
Brave Warrior Advisors, LLCUnited States$4.040B36
MARTINGALE ASSET MANAGEMENT L PUnited States$3.988B794
GLENVIEW CAPITAL MANAGEMENT, LLCUnited States$3.983B44
U.S. Capital Wealth Advisors, LLCUnited States$3.976B1,014
Ilex Capital Partners (UK) LLPUnited Kingdom$4.058B77
Munich Reinsurance Co Stock Corp in MunichGermany$4.068B175
Metis Global Partners, LLCUnited States$4.073B724